These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2349604)

  • 1. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
    Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of pretransplant prognosis in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Rodeck B; Duewel J; Schulz M; Schmidt FW; Brodehl J; Pichlmayr R
    Transplantation; 1991 Apr; 51(4):801-6. PubMed ID: 2014533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
    J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessment of monoethylglycinexylidide as preoperative liver function test in a rat model of liver cirrhosis and man.
    Kaneko H; Otsuka Y; Katagiri M; Maeda T; Tsuchiya M; Tamura A; Ishii T; Takagi S; Shiba T
    Clin Exp Med; 2001 Mar; 1(1):19-26. PubMed ID: 11467398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
    Lancet; 1989 Mar; 1(8639):640-2. PubMed ID: 2564460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients.
    Conti F; Dousset B; Cherruau B; Guérin C; Soubrane O; Houssin D; Calmus Y
    Clin Transplant; 2004 Jun; 18(3):235-41. PubMed ID: 15142042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score.
    Oellerich M; Hartmann H; Ringe B; Burdelski M; Lautz HU; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1116-9. PubMed ID: 8442062
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of one-year pretransplant survival in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Binder L; Pichlmayr R
    Hepatology; 1991 Dec; 14(6):1029-34. PubMed ID: 1959850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
    Testa R; Caglieris S; Risso D; Arzani L; Campo N; Alvarez S; Giannini E; Lantieri PB; Celle G
    Am J Gastroenterol; 1997 Dec; 92(12):2268-73. PubMed ID: 9399768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML; Luketic VA; Sanyal AJ; Thompson EB
    Ther Drug Monit; 1996 Aug; 18(4):372-7. PubMed ID: 8857553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.
    Botta F; Giannini E; Romagnoli P; Fasoli A; Malfatti F; Chiarbonello B; Testa E; Risso D; Colla G; Testa R
    Gut; 2003 Jan; 52(1):134-9. PubMed ID: 12477775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?
    Testa R; Valente U; Risso D; Caglieris S; Giannini E; Fasoli A; Botta F; Dardano G; Lantieri PB; Celle G
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):559-63. PubMed ID: 10755262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.
    Ercolani G; Grazi GL; Callivà R; Pierangeli F; Cescon M; Cavallari A; Mazziotti A
    Surgery; 2000 Apr; 127(4):464-71. PubMed ID: 10776439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoethylglycinexylidide test is more useful for evaluating liver function than indocyanine green test: case of a patient with remarkably decreased indocyanine green half-life.
    Oda Y; Kariya N; Nakamoto T; Nishi S; Asada A; Fujimori M
    Ther Drug Monit; 1995 Apr; 17(2):207-10. PubMed ID: 7624913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.